New studies, new discussions, but no new rules

24.02.2011 16:25

Cholesterol-lowering drugs protect at-risk patients

Two recently published large meta-analyses have reignited the discussion about the benefits of statins. But the old rule remains: When used correctly, cholesterol-lowering drugs are part of the standard repertoire in the treatment of patients with an increased risk of heart attacks, ischemic strokes and other cardiovascular events. This is emphasized by Prof. Dr. med. Hans-Christoph Diener from the German Society for Neurology (DGN) and Prof. Dr. med. Joachim Röther (left), President of the German Stroke Society (DSG).